Literature DB >> 29130298

Role of microRNAs (miRNAs) in the pathophysiology of diabetes mellitus.

Juhi Tiwari1, Gaurav Gupta2, Terezinha de Jesus Andreoli Pinto3, Rahul Sharma1, Kavita Pabreja4, Yogesh Matta1, Neha Arora1, Anurag Mishra5, Rakesh Sharma5, Kamal Dua6,7.   

Abstract

Diabetes mellitus is becoming the critical problem among the entire world and it is difficult to understand the molecular mechanism representing the concept of diabetic pathology. Recently the knowledge of the involvement of genetics in type 2 diabetes mellitus (T2DM) susceptibility has sketched a great concentration towards the transcriptional activity of β cells within the pancreas. This disease becomes the leading cause of death, so it is necessary to study the molecular pathogenesis, phenotypes, and characteristics to design the therapeutic parameters. Here in this review role of miRNA is being illustrated as it plays a crucial role in the pathogenesis, progression, and fate of beta cells of pancreas regulating the insulin secretion. Here in this review, we try to include the effects and pathophysiology of various miRNA in diabetes mellitus and on the various sites of the human body.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29130298     DOI: 10.23736/S0031-0808.17.03382-1

Source DB:  PubMed          Journal:  Panminerva Med        ISSN: 0031-0808            Impact factor:   5.197


  11 in total

Review 1.  Therapeutic Potential of miRNAs for Type 2 Diabetes Mellitus: An Overview.

Authors:  Pads Palihaderu; Bilm Mendis; Jmkjk Premarathne; Wkrr Dias; Swee Keong Yeap; Wan Yong Ho; A S Dissanayake; I H Rajapakse; P Karunanayake; U Senarath; D A Satharasinghe
Journal:  Epigenet Insights       Date:  2022-10-15

2.  miRNA-770-5p expression is upregulated in patients with type 2 diabetes and miRNA-770-5p knockdown protects pancreatic β-cell function via targeting BAG5 expression.

Authors:  Min Wang; Jilou Wei; Ting Ji; Kui Zang
Journal:  Exp Ther Med       Date:  2021-04-22       Impact factor: 2.447

3.  A microRNA‑24‑to‑secretagogin regulatory pathway mediates cholesterol‑induced inhibition of insulin secretion.

Authors:  Jing Yang; Yuncheng Lv; Zhibo Zhao; Wu Li; Sunmin Xiang; Lingzhi Zhou; Anbo Gao; Bin Yan; Lingling Ou; Hong Ling; Xinhua Xiao; Jianghua Liu
Journal:  Int J Mol Med       Date:  2019-05-31       Impact factor: 4.101

4.  The association of two common polymorphisms in miRNAs with diabetes mellitus: A meta-analysis.

Authors:  Guixin Li; Beibei Liu; Qianqian Jiang; Junli Zhang; Shengliang Xin; Keshu Xu
Journal:  Medicine (Baltimore)       Date:  2019-10       Impact factor: 1.889

Review 5.  The Pathophysiological Role of CoA.

Authors:  Aleksandra Czumaj; Sylwia Szrok-Jurga; Areta Hebanowska; Jacek Turyn; Julian Swierczynski; Tomasz Sledzinski; Ewa Stelmanska
Journal:  Int J Mol Sci       Date:  2020-11-28       Impact factor: 5.923

6.  Research Status of Differentially Expressed Noncoding RNAs in Type 2 Diabetes Patients.

Authors:  Rou Shi; Yingjian Chen; Yuanjun Liao; Rang Li; Chunwen Lin; Liangchang Xiu; Haibing Yu; Yuanlin Ding
Journal:  Biomed Res Int       Date:  2020-11-13       Impact factor: 3.411

7.  Increased miR-7641 Levels in Peritoneal Hyalinizing Vasculopathy in Long-Term Peritoneal Dialysis Patients.

Authors:  Raquel Díaz; Pilar Sandoval; Raul R Rodrigues-Diez; Gloria Del Peso; José A Jiménez-Heffernan; Ricardo Ramos-Ruíz; Carlos Llorens; Gustavo Laham; Mabel Alvarez-Quiroga; Manuel López-Cabrera; Marta Ruiz-Ortega; María A Bajo; Rafael Selgas
Journal:  Int J Mol Sci       Date:  2020-08-13       Impact factor: 5.923

8.  miR-450a-5p Eliminates MGO-Induced Insulin Resistance via Targeting CREB.

Authors:  Cuifeng Wei; Li Meng; Yuting Zhang
Journal:  Int J Stem Cells       Date:  2020-03-30       Impact factor: 2.500

Review 9.  Could IL-17A Be a Novel Therapeutic Target in Diabetic Nephropathy?

Authors:  Carolina Lavoz; Sandra Rayego-Mateos; Macarena Orejudo; Lucas Opazo-Ríos; Vanessa Marchant; Laura Marquez-Exposito; Antonio Tejera-Muñoz; Juan F Navarro-González; Alejandra Droguett; Alberto Ortiz; Jesús Egido; Sergio Mezzano; Raúl R Rodrigues-Diez; Marta Ruiz-Ortega
Journal:  J Clin Med       Date:  2020-01-19       Impact factor: 4.241

10.  Polygonatum sibiricum polysaccharides (PSP) improve the palmitic acid (PA)-induced inhibition of survival, inflammation, and glucose uptake in skeletal muscle cells.

Authors:  Jia-Luo Cai; Xiao-Ping Li; Yi-Lin Zhu; Gang-Qiang Yi; Wei Wang; Xin-Yu Chen; Gui-Ming Deng; Lei Yang; Hu-Zhi Cai; Qiao-Zhen Tong; Li Zhou; Mengying Tian; Xin-Hua Xia; Ping-An Liu
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.